28.06.2012: Vortrag im Rahmen der Sommerschule „Marine Biotechnologie“

 um 12:15 Uhr im Gr. Konferenzraum (WEST), GEOMAR, Düsternbrooker Weg 20

European Screening Port (ESP) is a contract research organization which operates across three main business areas: 

Drug Discovery – Working exclusively with academic and research institutes, ESP provides a complete drug discovery service covering all stages from target validation via small molecule screening to candidate selection

Biomarker and Translational Research – In their specialist laboratory facilities embedded in a University clinical research centre, they support biomarker discovery studies for clinical and pre-clinical research projects

Enabling Technologies – The company actively develops and benchmarks novel assay and screening technologies in partnership with the life-science industry.

http://screeningport.com/